Casaubon on Arabic and Turkish coins. A European network of exchange by Gigante, F, Burnett, A

Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia by Burnett, A, Russell, N, Hills, R

The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities by Chilton, L, Hills, R, Burnett, A, Harrison, C

High bax expression modulates response to treatment and survival in AML. by Truran, L, Kell, J, Nicholson, D, Harrison, G, Hoy, T, Burnett, A

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute... by Mead, A, Linch, D, Hills, R, Wheatley, K, Burnett, A, Gale, R

Association between reproducible flow cytometric methodology for measuring multidrug resistance and remission rates in AML by Pallis, M, Turzanski, J, Harrison, G, Wheatley, K, Langabeer, S, Burnett, A, Russell, N

Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic disease. by Mead, A, Gale, R, Hills, R, Gupta, M, Young, B, Burnett, A, Linch, D

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. by Watson, M, Buck, G, Wheatley, K, Homewood, JR, Goldstone, A, Rees, J, Burnett, A

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. by Burnett, A, Wheatley, K, Goldstone, A, Stevens, R, Hann, I, Rees, J, Harrison, G

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis... by Watson, M, Wheatley, K, Harrison, G, Zittoun, R, Gray, R, Goldstone, A, Burnett, A

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML by Lucas, C, Scott, L, Carmell, N, Holcroft, A, Hills, R, Burnett, A, Clark, R

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia... by Gale, R, Green, C, Allen, C, Mead, A, Burnett, A, Hills, R, Linch, D

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical rese... by Wheatley, K, Burnett, A, Goldstone, A, Hann, I, Stevens, R, Rees, J, Gray, R

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial by Russell, N, Burnett, A, Hills, R, Betteridge, S, Dennis, M, Jovanovic, J, Dillon, R, Grimwade, D

Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials by Hills, R, Gale, R, Linch, D, Huntly, B, Papaemmanuil, E, Vyas, P, Burnett, A, Russell, N

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials by Gale, R, Popa, T, Wright, M, Khan, N, Freeman, S, Burnett, A, Russell, N, Hills, R, Linch, D

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical... by Grimwade, D, Walker, H, Harrison, G, Oliver, F, Chatters, S, Harrison, C, Wheatley, K, Burnett, A, Goldstone, A

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial by Burnett, A, Hills, R, Nielsen, O, Freeman, S, Ali, A, Cahalin, P, Hunter, A, Thomas, I, Russell, N

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial. by Grimwade, D, Walker, H, Oliver, F, Chatters, S, Harrison, G, Wheatley, K, Burnett, A, Goldstone, A, Party, M

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative-Al... by Bradbury, C, Ward, J, Vyas, P, Russell, N, David, G, Hills, R, Burnett, A, Craddock, C, Sylvie, F